Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 11 of 11 for “"lorcaserin"”.

  1. Lorcaserin as a potential opioid-sparing adjunct

    … efficacy in preclinical models of chronic pain. Lorcaserin is a selective 5-HT2C receptor agonist and was reported to attenuate the abuse-related effects of oxycodone. The antinociceptive properties of 5-HT2C receptor agonists and their potential to alter the abuse-related effects of commonly …

    vcu Repository record for Lorcaserin as a potential opioid-sparing adjunct (opens in a new tab)

  2. The role of lorcaserin in obesity: identification of CNS targets using fMRI

    … of this widespread problem. The introduction of lorcaserin (Belviq®), a serotonin (5-hydroxytryptamine, 5-HT) agonist that selectively targets the 5-HT receptor subtype 2C (5-HT2C), has already exhibited great potential for combating the obesity epidemic since it was approved by the Food and Drug …

    bu Repository record for The role of lorcaserin in obesity: identification of CNS targets using fMRI (opens in a new tab)

  3. Improved satiety signalling in obesity with a novel combination treatment of Caralluma fimbriata Extract and Lorcaserin

    … The FDA approved the 5HT2cR-specific agonist Lorcaserin to treat obesity in 2012. However, the drug Lorcaserin has limited use for the long-term treatment of obesity due to concerns about side effects and it was withdrawn from sale in the USA in 2020. The current study aims to investigate …

    vu-aus Download PDF for Improved satiety signalling in obesity with a novel combination treatment of Caralluma fimbriata Extract and Lorcaserin (opens in a new tab)

  4. Exploring the impact of interventions for obesity and diabetes on the risk of cancer : focus on metformin and lorcaserin

    … studies) to a detrimental effect of lorcaserin observed in the follow-up of a large randomized trial. This thesis consists of two systematic reviews and meta-analyses with trial sequential analysis focusing on these drugs. In the case of lorcaserin, a nominally higher risk of cancer …

    brazil-ufrgs Repository record for Exploring the impact of interventions for obesity and diabetes on the risk of cancer : focus on metformin and lorcaserin (opens in a new tab)

  5. The Effect of 5-HT2C Receptor Activation on Nausea-Induced Behaviour in Rats

    … rats. Two chemically distinct 5-HT2C agonists (lorcaserin and CP-809101) were evaluated using the conditioned gaping model. At therapeutically relevant doses, lorcaserin caused rats to display conditioned gaping reactions. This effect was successfully blocked by pre-treating the animals with the …

    guelph Repository record for The Effect of 5-HT2C Receptor Activation on Nausea-Induced Behaviour in Rats (opens in a new tab)

  6. Eficacia y seguridad de liraglutida para manejo de sobrepeso y obesidad. Revisión sistemática y Metaanálisis en red

    … 4.02 [2.14, 7.52]). In the indirect comparison, Lorcaserin OR 3.77 (95% CI 3.17, 4.44) and Topiramate / Phentermine OR 2.03 (95% CI 1.65, 2.55) showed a higher proportion of patients with loss of weight of 5% or more. The proportion of non-severe adverse reactions was higher with Liraglutide …

    rosario Repository record for Eficacia y seguridad de liraglutida para manejo de sobrepeso y obesidad. Revisión sistemática y Metaanálisis en red (opens in a new tab)

  7. Treatment of adult obesity

    … treatment of obesity. Those are orlistat, lorcaserin and phentermine/topiramate. The surgical treatments reviewed include vertical banded gastroplasty, adjustable gastric banding, Roux-en Y gastric bypass, biliopancreatic diversion, and biliopancreatic diversion with duodenal switch. After …

    bu Repository record for Treatment of adult obesity (opens in a new tab)

  8. Strategies to Identify Therapeutic Opportunities in the Treatment of Addictive Disorders

    … agonist pimavanserin and 5-HT2CR agonist lorcaserin used alone or in combination demonstrate efficacy in suppressing measures of binge eating. Pharmacological studies further show that activation of the 5-HT2CR may suppress binge eating by decreasing the reinforcing and motivational …

    utmb Repository record for Strategies to Identify Therapeutic Opportunities in the Treatment of Addictive Disorders (opens in a new tab)

  9. An evaluation and comparison of current FDA-approved treatments for obesity

    … long-term medications. As a result, liraglutide, lorcaserin, naltrexone/bupropion extended-release, and phentermine/ topiramate extended-release became FDA-approved for long-term treatment of obesity. Each drug acts on a specific part of the CNS to modulate appetite and cause decreased food intake …

    bu Repository record for An evaluation and comparison of current FDA-approved treatments for obesity (opens in a new tab)

  10. Mechanisms by which Nicotine Enhances Pavlovian Approach Behavior and Responding for a Conditioned Reinforcer

    … impact of administering varenicline, bupropion, lorcaserin, and naltrexone on nicotine-enhanced responding for a conditioned reinforcer. Together, these data substantiate a role for nicotine in enhancing the motivating properties of CSs, and identify several pharmacological targets that influence …

    toronto-retro Repository record for Mechanisms by which Nicotine Enhances Pavlovian Approach Behavior and Responding for a Conditioned Reinforcer (opens in a new tab)

  11. A Two-Pronged Approach to Stemming the Opioid Epidemic: Preclinical Strategies for Substance Use Disorder Medications Development and Liquid Biopsy Detection of Inflammatory Pain

    … (5-HT) 5-HT2C receptor (5-HT2CR) agonist lorcaserin robustly diminishes the reinforcing value of the prescription opioid oxycodone (OxyContin®) and does not possess abuse liability. We also have identified a list of genes associated with high drug relapse vulnerability that should be …

    utmb Repository record for A Two-Pronged Approach to Stemming the Opioid Epidemic: Preclinical Strategies for Substance Use Disorder Medications Development and Liquid Biopsy Detection of Inflammatory Pain (opens in a new tab)